Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003079029 | SCV003460727 | uncertain significance | not provided | 2022-06-24 | criteria provided, single submitter | clinical testing | This variant occurs in the RNU4ATAC gene, which encodes an RNA molecule that does not result in a protein product. This variant is present in population databases (no rsID available, gnomAD 0.02%). This variant has been observed in individual(s) with clinical features of RNU4ATAC-related conditions (PMID: 28771251). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant disrupts the n.13C nucleotide in the RNU4ATAC gene. Other variant(s) that disrupt this nucleotide have been determined to be pathogenic (PMID: 26522830, 28623346, 30455926, 32109076). This suggests that this nucleotide is clinically significant, and that variants that disrupt this position are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV003079029 | SCV005378265 | pathogenic | not provided | 2024-04-15 | criteria provided, single submitter | clinical testing | Located in the critical region of stem II (PMID: 26522830); Also known as n.13C>G; This variant is associated with the following publications: (PMID: 34946966, 37225827, 26522830, 28771251) |